Mail Now

Press release

Why Celldex Therapeutics (CLDX) Stock Is Getting Hammered

Celldex Therapeutics, Inc. (NASDAQ: CLDX) shares are trading lower after the company announced a proposed public offering of 7.425 million shares at $27 per share.

What Else?

The offering entails an option for underwriters to purchase an additional ...

Full story available on

Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.

Disclaimer Press Release Banner